Document is current
Any future updates will be listed below
-
Authors
Gebhard, Anna
Lilienthal, Patrick
Metzler, Markus
Rauh, Manfred
Sager, Sebastian
Schmiegelow, Kjeld
Toksvang, Linea Natalie
Zierk, Jakob
-
Funding
Funding for this research was provided by:
The Carl and Ellen Hertz Foundation
The Children’s Cancer Foundation of Sweden (53/91)
The Children’s Cancer Foundation of Sweden (62/94)
The Children’s Cancer Foundation of Sweden (72/96)
The Children’s Cancer Foundation of Sweden (98/59)
The Danish Cancer Society (91–048)
The Danish Cancer Society (92–017)
The Danish Cancer Society (95–100-28)
The JPC Foundation
The Lundbeck Foundation (38/99)
The Minister Erna Hamilton Foundation
The Nordic Cancer Union (56–9257)
The Nordic Cancer Union (56–100-03–9102)
United States National Institutes of Health (RO1-GM28157)
United States National Institutes of Health (RO1-GM35720)
Deutsche Forschungsgemeinschaft (462065145)
Otto-von-Guericke-Universität Magdeburg
- License Information
-
More Information
Article History
Received: 21 March 2023
Accepted: 7 July 2023
First Online: 20 July 2023
Competing interests
: K.S. declares the following competing interests: Speaker and/or Advisory Board Honoraria from Illumina (2021), Jazz Pharmaceuticals (2020, 2021, 2023) and Servier (2020, 2021); Speaker fee from Amgen (2020, 2021) and Medscape (2020, 2021); Educational grants from Servier (2020, 2021, 2023); Research grant from Novo Nordisk Foundation (2020, 2022). All other authors declare no competing interests.
